サラ・ミシェル・ゲラーさんのインスタグラム写真 - (サラ・ミシェル・ゲラーInstagram)「Last week I shared some behind the scenes images of my first shoot back during the pandemic. It certainly was crazy to wear heels again, but it was a great afternoon! I'm thrilled to now share my new partnership with @coopervisionusa on the launch of the Brilliant Futures™ Myopia Management Program with MiSight® 1 day contact lenses. MiSight® 1 day contact lenses are the first and only soft contact lenses FDA-approved* to slow the progression of myopia in children ages 8-12 at the initiation of treatment.**1 Raising awareness of #myopia (also known as #nearsightedness) is close to my heart as my husband, myself, and our son are myopic. My husband and my conditions have worsened over time. We want our kids to have a chance for better vision. Learn more via link in bio. #ad #CooperVisionPartner #MiSight #BrilliantFutures #myopiamanagement *Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal. **Compared to a single vision 1 day lens over a 3 year period. 1 Chamberlain P, et al. A 3-year randomized clinical trial of MiSight® lenses for myopia control. Optom Vis Sci. 2019; 96(8):556-567. Compared to a single vision 1 day lens over a 3 year period.」8月27日 2時17分